Oncology Based In-vivo CRO Market Size Report 2024-2032: Key Players- Champions Oncology Inc., Charles River Laboratories International Inc., Crown Bioscience Inc., Eurofins Scientific

IMARC Group's report titled "Oncology Based In-Vivo CRO Market Report by Indication (Blood Cancer, Solid Tumors, and Others), Model (Syngeneic, Xenograft, Patient Derived Xenograft (PDX), and Others), Application (Hospitals, Rehabilitation Centers), and Region 2024-2032". The global oncology based in-vivo CRO market size reached US$ 1.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.9% during 2024-2032.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/oncology-based-in-vivo-cro-market/requestsample

Factors Affecting the Growth of the Oncology Based In-Vivo CRO Industry:

• Increasing Prevalence of Cancer Worldwide:

The global increase in cancer cases is a primary driver for the oncology-based in-vivo CRO market. As cancer continues to affect millions globally, the demand for effective treatments has never been more critical. This has led to a significant emphasis on research and development activities aimed at discovering novel therapies and drugs. Contract research organizations (CROs) specializing in in-vivo studies provide essential services, including drug efficacy testing and pharmacokinetics, to pharmaceutical companies. Their expertise in conducting complex oncology trials accelerates the development of oncology drugs, making them indispensable in the fight against cancer.

• Advancements in Technology and Methodologies:

The field of oncology research has seen remarkable technological advancements, enhancing the capabilities of in-vivo studies. Innovations such as CRISPR gene editing, advanced imaging techniques, and the development of humanized mouse models have transformed how cancer research is conducted. These technological advancements allow for more precise and efficient testing of cancer therapies, leading to more accurate results and faster development times. CROs that specialize in oncology and possess these advanced technologies are better equipped to meet the growing demands of pharmaceutical companies, making them a crucial component of the oncology research ecosystem.

• Strategic Collaborations and Partnerships:

Collaborations between pharmaceutical companies and oncology-based in-vivo CROs are vital for accelerating cancer research and therapy development. These partnerships leverage the strengths of both entities, combining the innovative drug candidates of pharmaceutical companies with the specialized research expertise of CROs. Through such collaborations, the drug development process can be expedited, facilitating quicker access to new cancer treatments for patients. Moreover, these partnerships often lead to the sharing of resources and knowledge, further advancing the field of oncology research.

Leading Companies Operating in the Global Oncology Based In-Vivo CRO Industry:

• Champions Oncology Inc.
• Charles River Laboratories International Inc.
• Crown Bioscience Inc.
• Eurofins Scientific
• Evotec SE
• ICON Plc
• Labcorp Drug Development (Laboratory Corporation of America Holdings)
• Living Tumor Laboratory
• Taconic Biosciences Inc.
• The Jackson Laboratory
• WuXi AppTec
• Xentech

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/oncology-based-in-vivo-cro-market

Oncology Based In-Vivo CRO Market Report Segmentation:

By Indication:

• Blood Cancer
• Solid Tumors
• Others

Solid tumors represent the largest segment due to the high prevalence of these cancers globally, necessitating extensive research and development efforts to discover effective treatments.

By Model:

• Syngeneic
• Xenograft
• Patient Derived Xenograft (PDX)
• Others

Patient derived xenograft (PDX) is the most prevalent model due to its ability to closely mimic human cancer biology, making it invaluable for preclinical oncology research.

By Application:

• Hospitals
• Rehabilitation Centers

On the basis of application , the market has been divided into hospitals and rehabilitation centers.

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America's dominance in the oncology based in-vivo CRO market is attributed to the region's advanced healthcare infrastructure, significant investment in cancer research, and the presence of leading pharmaceutical companies.

Global Oncology Based In-Vivo CRO Market Trends:

Governmental and non-governmental organizations provide funding and support for cancer research, encouraging further investments in oncology studies, which is a major trend in the market. In addition to this, there is a growing demand for personalized cancer treatments, driving research into targeted therapies and necessitating in-vivo studies, which is providing an impetus to the market.

Apart from this, the rapid expansion of pharmaceutical industries into emerging markets increases the demand for CRO services in oncology research, contributing to market growth.

Browse Other Research Report:

Vegan Ice Cream Market Size to Cross US$ 1,006.4 Million Globally by 2032 - Exclusive Report by IMARC Group : https://www.einnews.com/pr_news/685099201/vegan-ice-cream-market-size-to-cross-us-1-006-4-million-globally-by-2032-exclusive-report-by-imarc-group

Global Pharmaceutical Drug Delivery Market Size 2024-2032: Share by Top Brand, Sales, In-Depth Analysis, Growth Forecast : https://www.einnews.com/pr_news/685101741/global-pharmaceutical-drug-delivery-market-size-2024-2032-share-by-top-brand-sales-in-depth-analysis-growth-forecast

Bone Growth Stimulator Market Size 2024-2032: Share, Global Forecast Report, Top key players-Arthrex Inc.,DJO Global Inc : https://www.einnews.com/pr_news/685666024/bone-growth-stimulator-market-size-2024-2032-share-global-forecast-report-top-key-players-arthrex-inc-djo-global-inc

Petrochemicals Market Size 2024: Industry Trends, Outlook and Forecast Report 2032 : https://www.einnews.com/pr_news/685671200/petrochemicals-market-size-2024-industry-trends-outlook-and-forecast-report-2032

Wood Pellet Market Size to Reach US$ 22.2 Billion, Globally, by 2032 at 5.7% CAGR: IMARC Group b: https://www.einnews.com/pr_news/685683807/wood-pellet-market-size-to-reach-us-22-2-billion-globally-by-2032-at-5-7-cagr-imarc-group

Global Natural Sweeteners Market Size to Reach US$ 5.9 Billion by 2032 | IMARC Group : https://www.einnews.com/pr_news/686491565/global-natural-sweeteners-market-size-to-reach-us-5-9-billion-by-2032-imarc-group

Gene Therapy Market Size (2024-2032): Trends, Revenue Report, Top Key Players Growth, Analysis | IMARC Group : https://www.einnews.com/pr_news/686498975/gene-therapy-market-size-2024-2032-trends-revenue-report-top-key-players-growth-analysis-imarc-group

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

This release was published on openPR.